Venue: Lecture Theatre B, Level 7, Victorian Comprehensive Cancer Centre
Presenters: Professor Mark Dawson MBBS (Hons), BMedSci, FRACP, FRCPA, PhD (Cantb)
Increasingly research is looking beyond the script of life, our DNA, to the stage directions in the margins - forming the epigenome. We now know that a misplaced molecular scribble is central to the development of cancers such as acute myeloid leukaemia (AML). So can we edit epigenetics and rewrite cancer stories?
Join Professor Mark Dawson, Group Leader and Consultant Haematologist, Peter MacCallum Cancer Centre, to learn about the new epigenetic therapies currently being evaluated in clinical trials. Mark will focus on the molecular and cellular mechanisms of these therapies and the pre-clinical evidence for their efficacy, as well as the emerging challenges of potential resistance to this new class of targeted therapies. Professor Dawson has recently been selected as a Howard Hughes Medical Institute (HHMI) International Research Scholar, in recognition of his work as a leading early-career scientists working outside of the G7 group of countries.
Light lunch served from 12.30pm Presentation: 1pm- 2pm
from
https://events.unimelb.edu.au/events/8782-a-fresh-take-can-editing-epigenetics-help-us-change-cancer
No comments:
Post a Comment